Faus Moliner participates in the EU Pharmaceutical Law Forum
Jordi Faus participated in the dialogue Market Access Challenges and Developments for Pharmaceutical Firms
The 33rd edition of the European Pharmaceutical Law Forum, organized by Informa Connect, took place in Brussels from May 21-23, 2024.
As in previous editions, several round tables have addressed key issues and developments in EU Pharmaceutical Law.
Jordi Faus, together with Ilja Moree (Novartis AG) and Christian Jervelund (Copenhagen Economics), addressed the challenges faced by pharmaceutical companies in market access, as well as legal developments in this area. In his presentation, Jordi Faus presented various ideas on drug pricing and the nature of pricing and financing decisions. In addition, he explained how deferred payment systems and more sophisticated payment by results agreements can facilitate this access. He also highlighted the impact of drug price transparency in this area.